AzTrials
AzTrials

Postoperative Respiratory ComplicationsRuVent-ANCT06798883

Perioperative Respiratory Support and Postoperative Outcomes

An observational study of Postoperative Respiratory Complications, run by Russian Federation of Anesthesiologists and Reanimatologists.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the methodology and parameters of perioperative respiratory support (RS) and the frequency of postoperative pulmonary complications (PPCs) in the Russian Federation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Postoperative Respiratory Complications
How many people
1,000 participants
Where
No sites listed yet
Study dates
7 Apr 2025to 11 May 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will include adult patients (aged ≥18 years) undergoing surgical procedures under general anesthesia with respiratory support in participating medical centers across the Russian Federation. The study will focus on a wide range of surgical specialties, including but not limited to general surgery, orthopedics, neurosurgery, vascular surgery, and thoracic surgery. Patients with various comorbidities (e.g., obesity, chronic obstructive pulmonary disease, smoking, sleep apnea) that may influence respiratory support strategies will be included to provide a comprehensive assessment of perioperative respiratory management and its outcomes. No specific exclusion criteria will be applied, allowing for the inclusion of a diverse and representative cohort of surgical patients.

Who may be able to join

  • Patients aged ≥18 years undergoing surgical procedures with general anesthesia and respiratory support.

Who cannot join

  • No

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Andrey Yaroshetskiy, MD contact

+79859900148

yaroshetskiyandrei@me.com

Nikita Trembach, MD contact

+79528589299

trembachnv@mail.ru

About this study

Official title: Perioperative Respiratory Support and Postoperative Outcomes: Russian National Epidemiological Study "RuVent-A"

This study aims to evaluate the methodology and parameters of perioperative respiratory support (RS) and the frequency of postoperative pulmonary complications (PPCs) in the Russian Federation. The study will analyze respiratory support strategies, equipment availability, and their correlation with PPC outcomes in surgical patients.

Read the detailed description

Globally, around 230 million surgical procedures requiring general anesthesia and mechanical ventilation are performed annually. Postoperative pulmonary complications (PPCs) significantly impact clinical outcomes, increasing morbidity and hospitalization duration. Cohort studies have reported a 20-30% risk of PPCs in patients undergoing general anesthesia. Protective ventilation strategies, including low tidal volumes (6-8 mL/kg predicted body weight) and positive end-expiratory pressure (PEEP), have shown to reduce PPCs. However, high tidal volumes (10-15 mL/kg) remain prevalent in routine practice.

The "RuVent-A" study will collect data on respiratory support methodologies, initial ventilation parameters, types of surgical interventions, and associated PPC rates in the Russian Federation. This observational study will analyze patient and equipment data across participating centers without altering routine clinical practices.

Keywords
anesthesia, respiratory support, complications, mechanical ventilation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Postoperative Pulmonary Complications (PPCs)

    The frequency of postoperative pulmonary complications (PPCs) will be measured, including conditions such as atelectasis, hypoxemia, pneumonia, acute respiratory distress syndrome (ARDS), and bronchospasm. PPCs will be evaluated based on clinical and diagnostic criteria following surgery.

    Measured: 30 days after surgery

Secondary outcomes (7)
  1. Level of end-expiratory pressure during anesthesia

    The level of end-expiratory pressure during anesthesia used by the anesthesiologist will be assessed

    Measured: During surgery (intraoperative period).

  2. Use of Alveolar Recruitment Maneuvers During Anesthesia

    The frequency of alveolar recruitment maneuvers used during general anesthesia will be assessed.

    Measured: During surgery (intraoperative period).

  3. Frequency of Non-Invasive Ventilation and High-Flow Oxygen Therapy Post-Extubation

    The frequency of non-invasive ventilation (NIV) and high-flow oxygen therapy (HFOT) applied after extubation will be evaluated to determine their role in preventing PPCs.

    Measured: 30 days after surgery

  4. Duration of Intraoperative and Postoperative Mechanical Ventilation

    Duration of Intraoperative and Postoperative Mechanical Ventilation

    Measured: Intraoperative and up to 24 hours postoperatively.

  5. Incidence of Hypoxemia Post-Surgery

    The occurrence of hypoxemia (SpO2 <92%) after surgery will be documented, along with the requirement for oxygen therapy.

    Measured: 30 days after surgery

  6. Level of inspiratory oxygen fraction during anesthesia

    The level of inspiratory oxygen fraction during anesthesia used by the anesthesiologist will be assessed

    Measured: During surgery (intraoperative period).

  7. Level of tidal volume during anesthesia

    The level of tidal during anesthesia used by the anesthesiologist will be assessed

    Measured: During surgery (intraoperative period).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2025
  2. Study start7 Apr 2025 (estimated)
  3. Primary completion11 Apr 2025 (estimated)
  4. Study completion11 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06798883
Sponsor's protocol ID
FARCT0006
Acronym
RuVent-A
Status last verified
Jan 2025
First submitted
22 Jan 2025
Last updated
29 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual Participant Data (IPD) Sharing Statement Individual participant data (IPD) will not be shared due to the following reasons: Privacy and Confidentiality: The study involves sensitive patient data, and ensuring patient confidentiality is a top priority. Although the data will be anonymized, sharing IPD could still pose risks of re-identification. Regulatory and Ethical Considerations: Sharing IPD may not comply with local regulations and ethical guidelines governing patient data use in the Russian Federation. Study Scope: The primary objective of this study is to analyze aggregated data to inform clinical practices rather than to enable secondary analyses or external collaborations.

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Respiratory Complications, run by Russian Federation of Anesthesiologists and Reanimatologists.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Andrey Yaroshetskiy, MD (+79859900148, yaroshetskiyandrei@me.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of Postoperative Pulmonary Complications (PPCs) (time frame: 30 days after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2025; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in